Modification of Ca2+ Metabolism in the Rabbit Aorta as a Mechanism of Spasmolytic Action of Warifteine, a Bisbenzylisoquinoline Alkaloid Isolated from the Leaves of Cissampelos sympodialis Eichl. (Menispermaceae)

Journal of Pharmacy and Pharmacology - Tập 48 Số 3 - Trang 332-336 - 2011
Maria Regina de Freitas1, Steyner F. Côrtes1, George Thomas1, José Maria Barbosa‐Filho1
1Laboratório de Technologia Farmacêutica, Universidade Federal de Paraíba, Caixa Postal 5009, CEP 58051-970, Joaò Pessoa, PB, Brazil

Tóm tắt

Abstract The regulation of intracellular Ca2+ as a mechanism of spasmolytic activity of a bisbenzylisoquinoline alkaloid, warifteine, isolated from the leaves of Cissampelos sympodialis, Eichl (Menispermaceae) was studied in the rabbit aorta. Warifteine (pD'2 4.12 ± 0.09) similar to verapamil (pD'2 6.89 · 0.05) antagonized, in a noncompetitive and reversible manner, KCl-induced contractions, mediated by Ca2+ entry through voltage-operated channels. Noradrenaline-induced sustained contractions mediated by Ca2+ entry through receptor-operated channels were also inhibited by warifteine (IC50 6.03 × 10−5 m) and the standard agent sodium nitroprusside (IC50 1.9 × 10−8 m). In Ca2+-free medium, the alkaloid reduced the intracellular Ca2+-dependent transient contraction to noradrenaline by inhibiting the release of Ca2+ (IC50 2.6 × 10−5 m) from the stores and the refilling (IC50 1.9 × 10−5 m) of the intracellular stores. The standard agent, procaine, also inhibited the release of Ca2+ (IC50 3.2 × 10−5 m) but had no significant effect on Ca2+ uptake into the stores. Warifteine failed to affect intracellular Ca2+ stores sensitive to caffeine, while procaine inhibited (IC50 7.9 × 10−4 m) the release of Ca2+ from these stores. The results indicate that warifteine may cause muscle relaxation by inhibiting Ca2+ channels and by modifying the intracellular Ca2+ stores sensitive to noradrenaline.

Từ khóa


Tài liệu tham khảo

Ahn, 1988, Inhibitory effects of procaine on contraction and calcium movement in vascular and intestinal smooth muscles, Br. J. Pharmacol., 94, 789, 10.1111/j.1476-5381.1988.tb11590.x

Akoi, 1994, Relationship between cytosolic calcium concentration and force in the papaverine-induced relaxation of medial strips of pig coronary artery, Br. J. Pharmacol., 111, 489, 10.1111/j.1476-5381.1994.tb14763.x

Allen, 1994, The biochemical basis of the regulation of smooth-msucle contraction, Trends Biochem. Sci., 19, 362, 10.1016/0968-0004(94)90112-0

Araújo, 1991, Efeitos farmacológico do extrato hidroalcóolico de Cissampelos sympodialis, Resume VI Reunião Anual de Federaçâo das Sociedades de Biologia Experimental

Berridge, 1993, Inositol trisphosphate and calcium signalling, Nature, 361, 315, 10.1038/361315a0

Berridge, 1984, Inositol trisphosphate, a novel second messenger in cellular signal transduction, Nature, 312, 315, 10.1038/312315a0

Bolton, 1979, Mechanisms of action of transmitters and other substances on smooth muscle, Physiol. Rev., 59, 606, 10.1152/physrev.1979.59.3.606

Burgoyne, 1991, Locating intracellular calcium stores, Trends Biochem. Sci., 16, 319, 10.1016/0968-0004(91)90131-E

Correa, 1929, Dicionário das Plantas Úteis de Brasil e Exóticas Cultivadas, Min. da Agricultura, Rio de Janeiro, 5, 320

Côrtes, 1992, Ação espasmolitica de warifteina, urn alcalóide bisbenzilisoquinolinico isolado de C. sympodialis Eichl

Côrtes, 1992, Ação espasmolitica de warifteina em músculo liso, Resume VII Reunião Anual da Federaçâo das Sociedades de Biologia Experimental

Droogmans, 1977, Electro and pharmacomechanical coupling in the smooth muscle cells of the rabbit ear artery, J. Gen. Physiol., 70, 129, 10.1085/jgp.70.2.129

Drummond, 1987, The interaction of natural products with cellular signalling mechanisms, Phytother. Res., 1, 1, 10.1002/ptr.2650010103

Exton, 1990, Signalling through phosphatidylcholine breakdown, J. Biol. Chem., 265, 1, 10.1016/S0021-9258(19)40184-1

Galione, 1992, Ca2+ -induced Ca2+ release and its modulation by cyclic ADP-Ribose, Trends Pharmacol. Sci., 13, 304, 10.1016/0165-6147(92)90096-O

Galione, 1993, Cyclic ADP-Ribose: a new way to control calcium, Science, 259, 325, 10.1126/science.8380506

Iguchi, 1992, On the mechanism of papaverine inhibition of the voltage dependent Ca2+ current in isolated smooth muscle cells from the guinea-pig trachea, J. Pharmacol. Exp. Ther., 263, 194

Iino, 1989, Calcium-induced calcium release mechanism in guinea pig taenia caeci, J. Gen. Physiol., 94, 363, 10.1085/jgp.94.2.363

Irvine, 1992, Inositol phosphate and Ca2+ entry: toward a proliferation or a simplification?, Fed Am. Soc. Exp. Biol. J., 6, 3085

Karaki, 1987, Use of tension measurements to delineate the mode of action of vasodilators, J. Pharmacol. Methods, 18, 1, 10.1016/0160-5402(87)90013-1

Karaki, 1979, Mobilization of stored calcium for phasic contraction induced by norepinephrine in rabbit aorta, Eur. J. Pharmacol., 56, 237, 10.1016/0014-2999(79)90176-6

Karaki, 1986, Mechanisms of inhibitory action of sodium nitroprusside in vascular smooth muscle of rabbit aorta, Arch. Int. Pharmacodyn., 280, 230

Karaki, 1987, Caffeine-induced contraction in vascular smooth muscle, Arch. Int. Pharmacodyn., 285, 60

Kim, 1993, Synthesis and degradation of cyclic ADP-Ribose and NAD glycohydrolases, Science, 261, 1331, 10.1126/science.8395705

Kramer, 1979, Effects of phosphodiesterase inhibitors on cyclic nucleotide levels and relaxation of pig coronary arteries, Mol. Pharmacol., 16, 813

Meisheri, 1981, Evidence for two separate Ca2+ influx pathways in smooth muscle plasmalemma, J. Membr. Biol., 59, 19, 10.1007/BF01870817

Mikoshiba, 1993, Inositol 1,4,5-trisphosphate receptor, Trends Pharmacol. Sci., 14, 86, 10.1016/0165-6147(93)90069-V

Missiaen, 1992, Calcium ion homeostatis in smooth muscle, Pharmacol. Ther., 56, 191, 10.1016/0163-7258(92)90017-T

Miyamoto, 1976, Actions of papaverine on intestinal smooth muscle and its inhibition of cyclic AMP and GMP phosphodiesterases, Jpn. J. Pharmacol., 26, 114, 10.1254/jjp.26.114

Moncada, 1987, Endothelium-derived relaxing factor is identified as nitric oxide, Trends Pharmacol. Sci., 8, 365, 10.1016/0165-6147(87)90090-3

Nelson, 1990, Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone, Am. J. Physiol., 259, C3, 10.1152/ajpcell.1990.259.1.C3

Rasmussen, 1986, The calcium messenger system, New Engl. J. Med., 314, 1094, 10.1056/NEJM198604243141707

Reuter, 1983, Calcium channel modulation by neurotransmitters, enzymes and drugs, Nature, 301, 569, 10.1038/301569a0

Somlyo, 1968, Electromechanical and pharmacomechanical coupling in vascular smooth muscle, J. Pharmacol. Exp. Ther., 159, 129

Somlyo, 1994, Signal transduction and regulation in smooth muscle, Nature, 372, 231, 10.1038/372231a0

Sorrentino, 1993, Ryanodine receptors: how many, where and why?, Trends Pharmacol Sci., 14, 98, 10.1016/0165-6147(93)90072-R

Stoytcheva, 1992, Effects of the calcium antagonists diltiazem, verapamil and nitrendipine on the contractile responses of guinea-pig isolated ileum to electrical stimulation or carbachol, J. Pharm. Pharmacol., 44, 321, 10.1111/j.2042-7158.1992.tb03614.x

van Breemen, 1979, Na-Ca interactions in mammalian smooth muscle, Pharmacol. Rev., 30, 167

van Breemen, 1985, Ca2+ entry into vascular smooth muscle, Bayer-Simposium, IX, 58, 10.1007/978-3-642-70499-4_4

van Rossum, 1963, Cumulative dose-response curves, Arch. Int. Pharmacodyn., 143, 299